The Ministry of Health (MoH), Malaysia, has awarded Indian biopharma company Biocon a three-year contract to its Malaysian subsidiary, Biocon Sdn. Bhd., for supplying recombinant human insulin (rh-insulin) formulations manufactured at its large-scale biopharma facility in Johor, Malaysia. Biocon’s rh-insulin is Malaysia’s first locally manufactured biosimilar biologic product approved by the National Pharmaceutical Regulatory Authority (NPRA), Malaysia, for commercial sales in the country. Th...